140 related articles for article (PubMed ID: 30971808)
1. Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis.
Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Sohn S; Ebata R; Hamada H; Suzuki H; Ito K; Onouchi Y; Hong YM; Jang GY; Lee JK;
Pharmacogenomics J; 2020 Feb; 20(1):80-86. PubMed ID: 30971808
[TBL] [Abstract][Full Text] [Related]
2. Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease.
Kim HJ; Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Hong YM; Jang GY; Lee JK;
J Hum Genet; 2020 Apr; 65(4):421-426. PubMed ID: 31965063
[TBL] [Abstract][Full Text] [Related]
3. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
4. Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
Kuo HC; Wong HS; Chang WP; Chen BK; Wu MS; Yang KD; Hsieh KS; Hsu YW; Liu SF; Liu X; Chang WC
Circ Cardiovasc Genet; 2017 Oct; 10(5):e001625. PubMed ID: 29025760
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Tang B; Lo HH; Lei C; U KI; Hsiao WW; Guo X; Bai J; Wong VK; Law BY
Phytomedicine; 2020 Apr; 70():153208. PubMed ID: 32283413
[TBL] [Abstract][Full Text] [Related]
6. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD
Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559
[TBL] [Abstract][Full Text] [Related]
7. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
Mamtani M; Matsubara T; Shimizu C; Furukawa S; Akagi T; Onouchi Y; Hata A; Fujino A; He W; Ahuja SK; Burns JC
PLoS One; 2010 Jul; 5(7):e11458. PubMed ID: 20628649
[TBL] [Abstract][Full Text] [Related]
8. Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children.
Kim HE; Kim JJ; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Yu JJ; Park IS; Yun SW; Hong YM; Jang GY; Lee JK;
Pediatr Cardiol; 2012 Dec; 33(8):1259-63. PubMed ID: 22450355
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Sohn S; Johnson TA; Takahashi A; Kubo M; Tsunoda T; Ito K; Onouchi Y; Hong YM; Jang GY; Lee JK;
J Hum Genet; 2017 Dec; 62(12):1023-1029. PubMed ID: 28855716
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
[TBL] [Abstract][Full Text] [Related]
11. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
Zhang RL; Lo HH; Lei C; Ip N; Chen J; Law BY
Curr Opin Pharmacol; 2020 Oct; 54():72-81. PubMed ID: 32956895
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.
Kim JJ; Hong YM; Sohn S; Jang GY; Ha KS; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Lee JE; Shin ES; Jang JH; Lee YS; Kim SY; Lee JY; Han BG; Wu JY; Kim KJ; Park YM; Seo EJ; Park IS; Lee JK;
Hum Genet; 2011 May; 129(5):487-95. PubMed ID: 21221998
[TBL] [Abstract][Full Text] [Related]
13. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.
Onouchi Y; Suzuki Y; Suzuki H; Terai M; Yasukawa K; Hamada H; Suenaga T; Honda T; Honda A; Kobayashi H; Takeuchi T; Yoshikawa N; Sato J; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Murata Y; Ebata R; Higashi K; Ozaki K; Sasago K; Tanaka T; Hata A
Pharmacogenomics J; 2013 Feb; 13(1):52-9. PubMed ID: 21987091
[TBL] [Abstract][Full Text] [Related]
14. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.
Kuo HC; Hsu YW; Wu MS; Chien SC; Liu SF; Chang WC
J Microbiol Immunol Infect; 2016 Feb; 49(1):1-7. PubMed ID: 25556045
[TBL] [Abstract][Full Text] [Related]
16. High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.
Shendre A; Wiener HW; Zhi D; Vazquez AI; Portman MA; Shrestha S
Genes Immun; 2014 Dec; 15(8):534-42. PubMed ID: 25101798
[TBL] [Abstract][Full Text] [Related]
17. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X
Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
[TBL] [Abstract][Full Text] [Related]
18. Assessment of risk factors for Korean children with Kawasaki disease.
Kim JJ; Hong YM; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Sohn S; Ha KS; Hong SJ; Kim KJ; Park IS; Jang GY; Lee JK;
Pediatr Cardiol; 2012 Apr; 33(4):513-20. PubMed ID: 22105492
[TBL] [Abstract][Full Text] [Related]
19. Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.
Shrestha S; Wiener H; Shendre A; Kaslow RA; Wu J; Olson A; Bowles NE; Patel H; Edberg JC; Portman MA
Circ Cardiovasc Genet; 2012 Jun; 5(3):309-16. PubMed ID: 22565545
[TBL] [Abstract][Full Text] [Related]
20. A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.
Kuo HC; Hsu YW; Wu CM; Chen SH; Hung KS; Chang WP; Yang KD; Hsieh KS; Chen WC; Onouchi Y; Chang WC
PLoS One; 2013; 8(7):e69685. PubMed ID: 23894522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
